Daiwa Securities Group Inc. - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$14,000
+250.0%
185
+28.5%
0.00%
Q1 2022$4,000
-42.9%
1440.0%0.00%
Q4 2021$7,000
-36.4%
144
-14.8%
0.00%
Q3 2021$11,000
+57.1%
169
+77.9%
0.00%
Q2 2021$7,000
-22.2%
950.0%0.00%
Q1 2021$9,000
-18.2%
95
+4.4%
0.00%
Q4 2020$11,000
-47.6%
91
-61.3%
0.00%
Q3 2020$21,000
+133.3%
235
+16.3%
0.00%
Q2 2020$9,0000.0%2020.0%0.00%
Q1 2020$9,000
-30.8%
2020.0%0.00%
Q4 2019$13,0002020.00%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,750,000$260,122,0005.80%
Burrage Capital Management LLC 72,164$6,826,0005.53%
Consonance Capital Management LP 450,396$42,603,0004.54%
MPM BioImpact LLC 269,186$25,462,0003.20%
Orbimed Advisors 2,361,327$223,358,0002.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 81,541$7,711,0002.04%
SECTORAL ASSET MANAGEMENT INC 257,879$24,393,0001.85%
Nicholas Investment Partners, LP 218,847$20,701,0001.44%
Logos Global Management LP 140,000$13,243,0001.29%
SILVERARC CAPITAL MANAGEMENT, LLC 16,741$1,584,0000.86%
View complete list of TURNING POINT THERAPEUTICS I shareholders